颅内出血患者中度钝性胸主动脉损伤的管理
颅内出血稳定后术中肝素化未增加TEVAR相关并发症,无缺血性卒中或脊髓缺血,颅内出血加重仅1例。
要点
- 合并稳定颅内出血的中度BTAI患者行TEVAR未增加并发症风险。
- 颅内出血稳定后术中肝素化安全,不加重颅内出血。
- 合并颅内出血患者手术时间延迟(中位58.5小时 vs 26.5小时)。
核心结论
- 合并稳定颅内出血的中度BTAI患者行TEVAR不增加手术相关并发症风险。
- 术中肝素化在颅内出血稳定后使用安全,不加重颅内出血。
主要发现
- 合并颅内出血患者从入院到手术中位时间58.5小时,无颅内出血患者26.5小时。
- 无患者发生缺血性卒中或脊髓缺血。
- 颅内出血加重仅1例,该患者TEVAR前24小时因肺栓塞接受肝素输注。
关键数值与推荐
- 颅内出血患者中19/20(95%)在颅内出血符合稳定标准后接受术中肝素。
- 鱼精蛋白逆转用于80%的颅内出血患者和75%的无颅内出血患者。
临床怎么用
- 对合并稳定颅内出血的中度BTAI患者,可考虑在颅内出血稳定后行TEVAR并术中肝素化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blunt thoracic aortic injuries (BTAIs) are the second most common cause of death due to blunt-force trauma in the United States. Patients with minimal injuries do not typically require surgical repair, whereas patients with severe injuries are treated emergently. Moderate aortic injuries are repaired in a semielective fashion, but the optimal management of patients with moderate BTAI with associated intracranial hemorrhage (ICH) is unknown. We sought to analyze the management and outcomes of patients presenting with concomitant moderate BTAI and ICH. METHODS: Consecutive patients who received a thoracic endovascular aortic repair (TEVAR) at our institution for treatment of moderate BTAI between January 2014 and December 2017 were retrospectively reviewed as part of an institutional review board-approved protocol. Patients were classified by our BTAI classification into "minimal", "moderate", or "severe". ICH was identified on computed tomography scan and its severity determined by the neurosurgical team. Outcome measures included surgical timing and surgical outcomes. RESULTS: Fifty-two patients had a moderate BTAI and underwent TEVAR, 20 (38 %) of whom presented with ICH. Median time from admission to surgery was 58.5 hr for patients with ICH and 26.5 hr for non-ICH patients. Intraoperative heparin was administered in all patients without ICH and in 19 of 20 (95%) patients with ICH after the ICH met criteria for stability. Protamine reversal was utilized in 80% of patients with ICH and 75% of non-ICH patients. No patient developed ischemic stroke or spinal cord ischemia. Worsening ICH was seen in only one patient, who also received heparin infusion for pulmonary embolus 24 hr before TEVAR. There were no aortic-related mortalities in either group. Thirty-day all-cause mortality was 5% for patients with ICH and 3% for non-ICH patients. CONCLUSIONS: Patients with moderate BTAI and stable ICH are not at increased risk of TEVAR-related complications. Administration of intraoperative heparin during TEVAR appears to be safe and does not worsen ICH.
引用
- Quiroga E, Levitt MR, Czerwonko ME, et al. Management of Moderate Blunt Thoracic Aortic Injuries in Patients with Intracranial Hemorrhage. Ann Vasc Surg. 2020. PMID: 33359706. doi:10.1016/j.avsg.2020.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。